Q3 2024 |
13 |
$7.56B |
+$276M |
-$212M |
+$63.4M |
LQD, VCSH, VCIT, HYG, IGSB
|
13F-HR |
11/12/2024, 07:09 PM |
Q2 2024 |
12 |
$7.2B |
$0 |
-$795M |
-$795M |
LQD, VCSH, VCIT, HYG, IGSB
|
13F-HR |
7/31/2024, 08:00 PM |
Q1 2024 |
12 |
$8.05B |
$0 |
-$1.12B |
-$1.12B |
VCSH, LQD, VCIT, HYG, IGSB
|
13F-HR |
5/14/2024, 07:29 PM |
Q4 2023 |
12 |
$9.16B |
+$111M |
-$304M |
-$193M |
VCIT, VCSH, LQD, HYG, IGSB
|
Restatement |
5/14/2024, 07:20 PM |
Q3 2023 |
11 |
$8.85B |
+$417M |
$0 |
+$417M |
VCSH, VCIT, LQD, IGSB, HYG
|
13F-HR |
11/14/2023, 06:14 PM |
Q2 2023 |
11 |
$8.66B |
+$451M |
-$961M |
-$511M |
VCIT, VCSH, LQD, IGSB, HYG
|
13F-HR |
8/7/2023, 09:42 PM |
Q1 2023 |
11 |
$9.19B |
+$2.32B |
$0 |
+$2.32B |
VCSH, VCIT, LQD, IVV, HYG
|
13F-HR |
5/8/2023, 08:29 PM |
Q4 2022 |
7 |
$6.66B |
$0 |
$0 |
|
VCSH, LQD, VCIT, IGSB, HYG
|
13F-HR |
2/8/2023, 09:48 PM |